Welcome!
DBS Group Research
Broker's Calls
DBS indicates preference for REITs with high yields amid Fed's hawkish stance
The top S-REIT performers for the month of August were Cromwell European REIT, EC World REIT and Sabana REIT.
September 06, 2022
Broker's Calls
'Potential securitisation' of GuocoLand's income-producing portfolio could be 'significant share price catalyst': DBS
DBS is keeping its "buy" call on GuocoLand with an unchanged target price of $2.30.
September 05, 2022
Broker's Calls
DBS lifts Civmec's TP to 92 cents on the back of record FY2022 results and dividend surprise
DBS analyst Paul Yong sees Civmec continuing to pay a “steady” dividend of 3 Australian cents for the FY2023 and FY2024.
September 02, 2022
Broker's Calls
'Buy' ComfortDelGro on share price weakness: analysts
The analysts are remaining upbeat on CDG's prospects even if it will no longer be a constituent of the STI on Sept 19.
September 02, 2022
Broker's Calls
DBS keeps ‘hold’ on Micro-Mechanics Holdings albeit with lifted FY2023 earnings estimates on ‘intact’ longer-term trend
The group’s revenue stood in line with Ling’s expectations, while MMH’s net profit stood above expectations by 13%.
September 02, 2022
Broker's Calls
Broker's Digest: FCT, UG Healthcare, Mandarin Oriental International, ThaiBev, Wing Tai Holdings
See what the analysts have to say this week.
September 02, 2022
Broker's Calls
DBS expects consumer discretionary spending to receive a boost in September
MAS may consider another policy tightening move, though PM Lee Hsien Loong warned the central bank “not to overdo things."
September 01, 2022
Broker's Calls
Analysts maintain 'buy' call for Silverlake with higher TPs as order momentum picks up
The CGS-CIMB, DBS and PhillipCapital analysts have increased their respective TPs to 42 cents, 48 cents and 49 cents.
August 31, 2022
Broker's Calls
Analysts positive on ESR-LOGOS REIT amid recent acquisition of its first Japan asset
The REIT announced a purchase consideration of the centre of approximately $183.5 million, inclusive of rental support, on Aug 29.
August 31, 2022
Broker's Calls
Analysts optimistic on IHH Healthcare on further recovery in core businesses
IHH is currently trading at a very attractive FY22 EV/ebitda of 14x, close to -2 SD of its historical range.
August 30, 2022